In the mouse model of MLL-AF9-driven leukemia, the MLL-AF9Uhrf1Δ/Δ mice showed a significantly longer median survival (74 days) as compared with the MLL-AF9Uhrf1fl/fl mice (54.5 days; Fig. 2b). This evidence concerns the gene KMT2A and leukemia.